October 18, 2007: Cialis Labeling Changes

US-Food and Drug Administration or US-FDA declares that labeling on erectile dysfunction or ED medicines such as Cialis, Levitra, and Viagra will be displaying information on their labels regarding the potential risks of abrupt loss of hearing and to lead the customers on what they should do if they experience abrupt problems with their hearing. These labeling changes are results of cases where patients who are using ED medications reported that they experience a sudden loss of hearing and sometimes accompanied with dizziness and/or ringing in the ears. For those who are taking Cialis, Levitra, or Viagra, and there is a sudden loss of hearing, the FDA recommends to stop using the medication and seek immediate medical attention.

July 12, 2006: FDA Warns Consumers about Dangerous Ingredients in “Dietary Supplements” Promoted for Sexual Enhancement

The US Food and Drug Administration is giving warnings to consumers to avoid buying or take Zimaxx, Libidus, Nasutra, Vigor-25, Neophase, 4EVERON,  or Actra-Rx. These products are marketed and sold on websites as “dietary supplements” for curing erectile dysfunction and improving sexual performance. The fact is that they are illegal drugs that have potentially harmful hidden ingredients. These hidden ingredients are the same or identical to the active ingredients found in FDA-approved erectile dysfunction drugs like Viagra and Levitra. Since the ingredients are undeclared in any of these illegal products’ labels, customers do not know of the interactions with other treatments that can result in detrimental effects.

October 20, 2005: Public Citizen Calls on FDA to Require New Warnings for Erectile Dysfunction Drugs.

Public Citizen, a national non-profit consumer advocacy organization, requested the US-Food and Drug Administration to require black box warnings immediately to alert doctors and patients about the risks of possible permanent loss of vision-related with the use of the famous erectile dysfunction drugs including Cialis. Public Citizen also requested that warning is placed to the professional package and should be in bold letters and surrounded by a black box to make it stand out.

July 8, 2005: FDA Approves New Labeling for Erectile Dysfunction Drugs

The FDA-approved updated labeling for erectile dysfunction drugs such as Cialis, Levitra, and Viagra to show a small number of post-marketing reports of abrupt loss of vision which is attributed to NAION, a medical condition where the flow of blood is obstructed to the optic nerve, thus, causing blindness. Cialis, Levitra, and Viagra users are recommended to stop immediately taking any of these drugs and to consult with a doctor right away or healthcare professionals if they are experiencing abrupt or loss of vision in one or both eyes.